SI Group To Acquire Albemarle's Antioxidants Business
Manufacturer of chemical intermediates and specialty resins SI Group will acquire Albemarle's entire antioxidants business.
The SI Group, Schenectady, New York, has signed a deal to acquire the antioxidants, Ibuprofen, and related businesses and assets from Albemarle Corp., Baton Rouge, Louisiana. This is said to be largest deal in the 108-year history of SI Group, a global developer and manufacturer of chemical intermediates and specialty resins.
The acquisition, slated for completion later this year, includes the entire Albemarle antioxidants business for lubricants, fuel, and polymer stabilization. Albemarle’s products for the latter include Ethanox primary phenolic antioxidants and Ethaphos secondary phosphorus antioxidants. Also included is the Alblend line of blends of the two in masterbatch form, all of which have wide use in a range of polyolefins, styrenics, and engineering thermoplastics.
Related Content
-
ICIS Launches: Ask ICIS Generative AI Commodities Assistant
Said to be the first of its kind, this AI assistant will enhance access to ICIS’ intelligence and insights for the energy and chemical markets.
-
K 2022 Additives & Materials: Sustainability in the Lead
Nearly all of the new additives highlighted at the big show are aimed at enhancing recyclability of commodity resins and some volume engineering resins such as nylon and PC. A few new materials, on which we had not previously reported, also surfaced at K 2022.
-
SI Group Gets FDA Approval Extension for Weston 705 & 705T
SI’s phosphite antioxidants get ‘green light’ for use in PET food-contact packaging
